Hyaluronic acid Q-Med

Acid suppression

Management of complications

Pain management

Perioperative Management

Myfortic mycophenolic acid regulatory update

Mycophenolic acid derivative 118 improves outcome of skin grafts by suppressing IL-17 production

Nanogel-based delivery of mycophenolic acid ameliorates systemic lupus erythematosus

Systemic lupus erythematosus (SLE) is disease in which the immune system mistakenly attacks healthy tissues, resulting in inflammation and tissue damage. Current treatments are focused on suppression...

A nanogel-based treatment for lupus

(Journal of Clinical Investigation) In this issue of the Journal of Clinical Investigation, Tarek Fahmy and colleagues at Yale University report the development of a nanogel-based delivery system that...

In Development - A Nanogel-Based Treatment For Lupus

Systemic lupus erythematosus (SLE) is disease in which the immune system mistakenly attacks healthy tissues, resulting in inflammation and tissue damage. Current treatments are focused on suppression...

Genevac Evaporator can Handle Highly Corrosive Chemicals and Acids

Genevac's Acid-Resistant EZ-2 Plus Evaporator uses inert and corrosion-proof materials to enable it to withstand up to 6N Hydrochloric acid, 70% Nitric acid and most acid chlorides including thionyl c...

PolyRemedy introduces HealSmart Hyaluronic Acid Dressing

PolyRemedy, a US-based provider of wound management systems, has added Hyaluronic Acid (HA) to its HealSmart Antimicrobial Dressings.

Omthera asserts Epanova superiority but US filing delayed to next year

Omthera Pharmaceuticals is determined to show that Epanova, its free fatty acid formulation of omega-3 that contains both eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), is superior to Ama...

The pharmacokinetic interaction between mycophenolic acid and cyclosporine revisited: a commentary on "Mycophenolic acid glucuronide is transported by multidrug resistance-associated protein 2 and this transport is not inhibited by cyclosporine, tacrolimu

Pharmacokinetics of tacrolimus and mycophenolate mofetil in renal transplant recipients on a corticosteroid-free regimen.

Purpose The pharmacokinetics of both tacrolimus and mycophenolic acid in renal transplant recipients on a corticosteroid-free regimen was evaluated. Methods Upon administration of steady-state mornin...

Race and drug formulation influence on mycophenolic Acid pharmacokinetics in stable renal transplant recipients.

Limited mycophenolic acid (MPA) data are available comparing racial influence on mycophenolate mofetil (MMF) and enteric-coated mycophenolate sodium (EC-MPS) pharmacokinetics.

Therapeutic drug monitoring of mycophenolic acid: a potential treatment for lupus nephritis.

Mycophenolate mofetil, an immunosuppressant approved for the prevention of transplant rejection, has been used in patients with lupus nephritis. Lertdumrongluk et al.(1) suggest that mycophenolic acid...

Mycophenolic Acid Inhibits Replication of Japanese Encephalitis Virus.

Background: Japanese encephalitis is a major public health problem in several parts of Asia, particularly India, Nepal, Sri Lanka and Myanmar (Burma). Despite its public health implications, there are...